{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
22nd Century Group, Inc.
Is 22nd Century Group, Inc. technically bullish or bearish?
As of June 20, 2025, 22nd Century Group, Inc. shows a mildly bearish trend, with daily moving averages indicating bearish momentum, while weekly indicators present mixed signals, and the stock has underperformed the S&P 500 with a year-to-date return of -98.56%.
Is 22nd Century Group, Inc. technically bullish or bearish?
As of June 20, 2025, 22nd Century Group, Inc. shows a mildly bearish trend with mixed technical indicators, including bearish daily moving averages and a mildly bullish weekly MACD, suggesting a lack of strong momentum.
Who are in the management team of 22nd Century Group, Inc.?
As of March 2022, the management team of 22nd Century Group, Inc. includes Ms. Nora Sullivan as Chairman of the Board, along with Independent Directors Dr. Michael Koganov, Mr. Roger O'Brien, and Mr. Richard Sanders.
What does 22nd Century Group, Inc. do?
22nd Century Group, Inc. is a plant biotechnology company that genetically modifies nicotine in tobacco and cannabinoids in cannabis. As of March 2025, it reported net sales of $6 million and a net loss of $3 million, with a market cap of $3.63 million.
How big is 22nd Century Group, Inc.?
As of Jun 18, 22nd Century Group, Inc. has a market capitalization of 3.63 million, with net sales of 23.88 million and a net profit of -13.31 million over the last four quarters. Shareholder's funds are 4.01 million, and total assets are 21.67 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
